A company still losing money with growing sales. Institutions are trimming.
Facts from SEC filings, not a recommendation.
From USL's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: $13.3M, turned positive from a loss the year before.
Move the sliders to your own view of USL. Starting points are the company's recent numbers.
What today's price needs: with a 50% margin and a 15x P/E, sales could shrink about 11% a year for 5 years and still match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
From annual reports filed with the SEC. Gross margin doesn't apply to banks and insurers, so it isn't scored. Not in this company's SEC data, so not scored: return on equity 15%+, net margin 10%+, share count not growing. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions cut 46.4% from their holdings. 9 bought, 12 sold.
No offerings, red flags or new big holders. Clean record.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page